Caplight Logo









Lewei Pharmaceutical

Lewei Pharmaceutical

Private
JiangsuHealthcare & Life Scienceswww.lavianacorp.com.cn

Last Round

Series C

Dec 27, 2022

Total Funding Raised

$141.58M

Company Overview

Laviana is a pharmaceutical outsourcing company that specializes in transforming innovative medicine from laboratory to industrial processes, optimizing market-based drug research, and utilizing advanced analytical methods for drug development and testing.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Clinical Trials, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationsmall molecule CDMOAPI manufacturingcontract manufacturingsmall molecule drugsprocess R&DCMC servicescustom synthesispharmaceutical outsourcingcommercial manufacturingpilot scale productiondrug intermediatesFDA compliancechiral synthesisfluorine chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lewei Pharmaceutical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lewei Pharmaceutical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CDec 27, 2022
Series COct 13, 2021
Series BAug 26, 2019
Series BJan 2, 2018
Series AMar 1, 2014
View all Funding Rounds

Lewei Pharmaceutical Investors

Notable investors and investment history

InvestorRounds
ABC CapitalSeries B
V-CapitalSeries B
LYFE CapitalSeries B
Yingke PESeries C
Huayi CapitalSeries B
HRVC CapitalSeries C
HY CapitalSeries C
View all Investors

Lewei Pharmaceutical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lewei Pharmaceutical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lewei Pharmaceutical's valuation, stock price, and market status.

Firmographic Details

HeadquartersJiangsu
Year Founded2005
Last FundingDec 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.